ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements
Invesco Mutual Fund schemes bought 44,20,453 Sahajanand Medical Technologies shares in the open market. Their stake rose to 5.0549%, with no transaction price disclosed.
Sahajanand Medical Technologies scheduled a board meeting for 5 November 2026 to consider Q2 and half-year financial results. No financial figures are disclosed yet.
Sahajanand Medical Technologies received a DGGI summons under GST Act Section 70 for books verification. The company says there is no material financial impact at this stage.
Sahajanand Medical Technologies disclosed its Key Managerial Personnel authorized to determine materiality under LODR Reg 30(5). The filing lists the MD & CEO, CFO, and Company Secretary with contact details.